rs62642575
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM1PP5
The NM_000350.3(ABCA4):c.4610C>T(p.Thr1537Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,614,118 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T1537T) has been classified as Likely benign.
Frequency
Consequence
NM_000350.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCA4 | NM_000350.3 | c.4610C>T | p.Thr1537Met | missense_variant | 31/50 | ENST00000370225.4 | NP_000341.2 | |
ABCA4 | XM_047416704.1 | c.4388C>T | p.Thr1463Met | missense_variant | 30/49 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCA4 | ENST00000370225.4 | c.4610C>T | p.Thr1537Met | missense_variant | 31/50 | 1 | NM_000350.3 | ENSP00000359245.3 | ||
ABCA4 | ENST00000460514.1 | n.104C>T | non_coding_transcript_exon_variant | 2/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000131 AC: 33AN: 251474Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135912
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461818Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727212
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152300Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74474
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 11, 2022 | Identified without a second ABCA4 variant in individuals with retinal dystrophy (Rivera et al., 2000; Weisschuh et al., 2020; Sun et al., 2021; Ng et al., 2022); Identified in the heterozygous state in patients with nonsyndromic orofacial clefting (Peng et al., 2016); Published functional studies suggest a damaging effect with approximately 60% lower ATPase activity and 60% lower phospholipid transport activity compared to wild type (Quazi et al., 2013); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24097981, 34426522, 27527345, 31630094, 32531858, 33846575, 33301772, 10958763, 28118664) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 14, 2024 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 1537 of the ABCA4 protein (p.Thr1537Met). This variant is present in population databases (rs62642575, gnomAD 0.1%). This missense change has been observed in individual(s) with clinical features of Stargardt disease (PMID: 28118664, 31630094, 33301772; Invitae). ClinVar contains an entry for this variant (Variation ID: 99306). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects ABCA4 function (PMID: 24097981). For these reasons, this variant has been classified as Pathogenic. - |
not provided, no classification provided | literature only | Retina International | - | - - |
Severe early-childhood-onset retinal dystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.012%). Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product (PMID:24097981). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.93; 3Cnet: 0.99). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with ABCA4 related disorder (ClinVar ID: VCV000099306 / PMID: 10958763). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. - |
Retinal dystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2020 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jun 05, 2019 | The ABCA4 c.4610C>T, p.Thr1537Met variant (rs62642575) is reported in the medical literature in two individuals with Stargardt disease, but information on an additional pathogenic variant in these individuals was not provided (Rivera 2000, Schulz 2017). The variant is reported in the ClinVar database (Variation ID: 99306) and in the general population with an allele frequency of 0.01% (34/282866 alleles) in the Genome Aggregation Database. The amino acid at this position is highly conserved and computational algorithms (PolyPhen-2, SIFT) predict this variant is deleterious. Cell culture experiments show this variant slightly reduces function of the protein. However, due to limited information, the clinical significance of the variant is uncertain at this time. References: Quazi F et al. Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants. J Biol Chem. 2013 Nov 29;288(48):34414-26. Rivera A et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet. 2000 Oct;67(4):800-13 Schulz HL et al. Mutation Spectrum of the ABCA4 Gene in 335 Stargardt Disease Patients From a Multicenter German Cohort-Impact of Selected Deep Intronic Variants and Common SNPs. Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):394-403. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at